Insider · CIK 0001730038
Bahija Jallal
Files at ELV (Elevance Health, Inc.), IMCR (Immunocore Holdings plc). First filing Feb 19, 2026, latest Feb 19, 2026.
Bahija Jallal files SEC Form 4 as CEO and director at IMCR (Immunocore Holdings plc), and also at ELV (Elevance Health, Inc.). Since Feb 19, 2026, Bahija Jallal has reported 0 open-market buys worth $0 and 1 open-market sell worth $371k, the latest filed on Feb 19, 2026.
A track record needs three past buys with six months of prices behind them; Bahija Jallal has 0, so none is measured yet.
The newest scored trade: sold $371k of IMCR on Feb 18, 2026, filed Feb 19, 2026, scored 50 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $371k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMCR: Immunocore Holdings plc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Immunocore Holdings plc | $371k 11,474 shares | -48% | +33% from low-19% from high |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 13, 2026 | ELV Elevance Health, Inc. | AGrant or award Common Stock | +563 | $0.00 | $0 | 5,351 | May 15, 2026 |
| Feb 17, 2026 | IMCR Immunocore Holdings plc | MOption exercise Ordinary Shares | +23,817 | $0.00 | $0 | 23,817 | Feb 19, 2026 |
| Feb 18, 2026 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares | -11,474 | $32.35 | $371k | 12,343 | Feb 19, 2026 |
| Feb 17, 2026 | IMCR Immunocore Holdings plc | MOption exercise Restricted Share Unitsderivative | -23,817 | $0.00 | $0 | 71,453 | Feb 19, 2026 |
| Feb 17, 2026 | IMCR Immunocore Holdings plc | AGrant or award Restricted Share Unitsderivative | +88,573 | $0.00 | $0 | 88,573 | Feb 19, 2026 |
| Feb 17, 2026 | IMCR Immunocore Holdings plc | AGrant or award Employee Share Option (Right to Buy)derivative | +395,066 | $0.00 | $0 | 395,066 | Feb 19, 2026 |
| May 14, 2025 | ELV Elevance Health, Inc. | AGrant or award Common Stock | +601 | $0.00 | $0 | 4,788 | May 16, 2025 |
| Feb 17, 2025 | IMCR Immunocore Holdings plc | AGrant or award Employee Share Option (Right to Buy)derivative | +405,824 | $0.00 | $0 | 405,824 | Feb 19, 2025 |
| Feb 17, 2025 | IMCR Immunocore Holdings plc | AGrant or award Restricted Share Unitsderivative | +95,270 | $0.00 | $0 | 95,270 | Feb 19, 2025 |
Questions about Bahija Jallal
Answered from the filings on this page, as of the latest one.
Is Bahija Jallal buying or selling?
In the last 12 months Bahija Jallal reported 0 open-market buys worth $0 and 1 open-market sell worth $371k on SEC Form 4; the latest was sold $371k of IMCR on Feb 18, 2026. Grants, option exercises and tax withholding are not counted.
How did Bahija Jallal's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bahija Jallal has 0.
Where does Bahija Jallal file Form 4?
Bahija Jallal has filed Form 4 at IMCR (Immunocore Holdings plc) as CHIEF EXECUTIVE OFFICER; ELV (Elevance Health, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.